Testing for Hormone Receptors is an essential laboratory investigation carried out in breast cancer tissue that is conducted to establish if the cancerous hormones, such as progesterone and estrogen, have an impact on cells. Testing for Hormone Receptors is one of the most important diagnostic tests in determining how breast cancer develops and can be effectively treated.
Hormone sensitivity is present in a considerable percentage of breast cancer tumors produced in the body. Testing for Hormone Receptors enables doctors to determine whether the cancer cells are likely to respond to hormonal therapy.
In modern medicine, breast cancer treatment is based on precision medicine, which involves advanced imaging technologies, molecular pathology, and personalized treatment, among other approaches. Testing cancer cells for hormone sensitivity is part of advanced breast cancer diagnostic programs at the Advanced Cancer Centers of Excellence.
Testing for Hormone Receptors is a test that determines whether breast cancer cells have receptors for:
Hormone receptors are specific types of protein structures within or on the cell surface.
The presence of these hormone receptors suggests that the cancer is either:
A positive result for hormone receptor testing suggests that the cancer might be treated effectively with hormonal therapies, also known as endocrine therapy.
Hormone Receptor Testing is a vital laboratory test involved in breast cancer diagnosis and staging.
It allows physicians to:
This diagnostic method is regarded as a must-do test in breast cancer analysis.
The human body produces hormones that participate in various biological processes.
For some breast cancers:
The growth of cancerous tumors may be accelerated by hormones if the tumors express hormone receptors.
Inhibition of hormone receptors will help inhibit tumor proliferation.
Cancer cells that express estrogen receptors are classified as ER-positive cancers; their growth is stimulated by estrogen.
ER-positive tumors are very common.
Testing of progesterone receptors detects whether this hormone is responsible for tumor proliferation.
The breast cancer may be:
The above-mentioned cancers tend to:
In case of absence of receptors, the cancer is:
Other therapies may prove to be effective.
Testing for hormone receptors is performed using samples obtained through:
Specialist lab methods are used to evaluate hormone receptors.
The most commonly used test for evaluating hormone receptors is Immunohistochemistry (IHC).
The procedure:
Thus, it is possible to define whether the cancer responds to hormonal therapy.
In the report from a specialist, one can find:
The tumor may:
Hormone receptor testing plays a significant role in breast cancer staging workup.
It enables physicians to:
It is commonly conducted alongside:
When breast cancer is hormone receptor-positive, the patient can receive endocrine therapy.
Some forms of hormonal therapy include:
This therapy will help in:
An individualized treatment plan will be developed according to receptor status and cancer stage.
The hormone receptor assessment is important when treating patients suffering from:
In addition to Hormone receptor testing, the following lab tests may be performed on breast tumors:
The HER2 test detects whether the HER2 protein is overexpressed in the cancer. If cancer cells are HER2-positive, targeted treatments can be used.
Advanced molecular profiling identifies the tumor's genetic and biological makeup.
It will assist in:
Technologies in modern oncology have completely changed the management of breast cancer.
Centers of Excellence in Comprehensive Cancer Care offer comprehensive care, including:
A multidisciplinary approach makes the processes more coordinated and effective.
Breast care centers usually have a multidisciplinary team, which may consist of:
Multidisciplinary care enables the creation of individualized treatment plans.
services offered by comprehensive care centers for breast cancer include:
These services will contribute to a better outcome.
A visit to the medical institution is required for the following complaints:
Tissue testing plays a key role in the early stages.
Tender Palm Super-Speciality Hospital offers advanced Hormone Receptor Testing in Lucknow, India, at an affordable cost to determine the hormone receptor status of breast cancer cells and help guide treatment planning. Our experienced oncology and pathology teams use reliable testing methods to provide accurate results and timely reports. With expert interpretation, comprehensive diagnostic support, and guidance on suitable treatment options, we provide complete care throughout the breast cancer diagnosis and treatment journey. Trust Tender Palm for accurate hormone receptor testing, experienced specialists, and quality cancer care.
Call us at +91-9076972161
Email at care@tenderpalm.com